Position in TGTX
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,164,288
+$600,313 QoQ
Shares Held
21,192
+24.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#178
of 425 holders
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Envestnet Portfolio Solutions, Inc. holds $15,944,229 across 18 Biotechnology names. TGTX ranks #4 (7.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
8,064 | $4,005,630 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
8,030 | $1,934,989 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
4,635 | $1,395,274 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
This page
|
21,192 | $1,164,288 | |
| 5 | PTCT |
Ptc Therapeutics, Inc.
|
13,730 | $1,119,956 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
10,617 | $923,148 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
11,409 | $892,982 | |
| 8 | 21,996 | $691,334 |
All Filings in TGTX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,164,288 | 21,192 | Shares | Sole | 2026-07-20 | |
| 2026-03-31 | $563,975 | 16,977 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $536,103 | 17,984 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $502,173 | 13,901 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $543,053 | 15,089 | Shares | Sole | 2025-07-25 | |
| 2024-12-31 | $216,027 | 7,177 | Shares | Sole | 2025-02-10 | |
| No filing history on record for this holder in this stock. | ||||||